There were 1,789 press releases posted in the last 24 hours and 427,252 in the last 365 days.

Urolithiasis Management Device Market to Reach USD 1.55 Billion by 2032 with 5% CAGR | Reports and Data

Reports And Data

Reports And Data

The Urolithiasis Management Device Market value for was USD 1.05 billion in 2022 and is expected to reach USD 1.55 billion in 2032 growing at a CAGR of 5%.

NEW YORK CITY, NY, UNITED STATES, July 12, 2023/ -- The Urolithiasis Management Device Market was valued at USD 1.05 billion in 2022, and it is projected to reach USD 1.55 billion in 2032, with a compound annual growth rate (CAGR) of 5% during the forecast period. The growth of the market is primarily driven by the increasing incidence of urolithiasis and advancements in urological equipment technology. Additionally, the market is fueled by rising healthcare costs and the growing demand for minimally invasive procedures.

Various tools are utilized for managing urolithiasis, including lithotripsy machines, ureteroscopes, and different instruments for stone removal. Among these, lithotripsy devices, which use shockwaves to break down urinary tract stones, are the most widely used for urolithiasis management. Consequently, there is an anticipated increase in demand for lithotripsy devices during the forecast period, owing to their successful track record in treating urolithiasis.

Get Free Sample PDF (To Understand the Complete Structure of this Report [Summary + TOC]) @

Key players in the Urolithiasis Management Device Market:

• Olympus Corporation
• Boston Scientific Corporation
• Cook Medical
• C. R. Bard, Inc.
• Dornier MedTech GmbH
• Stryker Corporation
• Richard Wolf GmbH
• Siemens AG
• Elmed Medical Systems
• Convergent Laser Technologies
• Lumenis Ltd.

Ureteroscopes play a crucial role in the diagnosis and removal of stones from the urinary tract, offering a minimally invasive approach with high success rates. As a result, the demand for ureteroscopes is expected to grow steadily throughout the projected period.

Segments Covered in the Report –

By Product Type Outlook -

• Extracorporeal Shock Wave Lithotripsy
• Ureteroscopes
• Retrieval Devices
• Intracorporeal Lithotripsy
• Others

By End-use Outlook -

• Hospitals
• Ambulatory Surgical Centers
• Others

Access Full Report Description with Research Methodology and Table of Contents @

Strategic development:

• In 2021, Boston Scientific Corporation introduced the LithoVue Empower Retrieval Deployment Device, which is designed for the removal of kidney stones. This device aims to simplify the stone removal process and improve clinical outcomes for patients.

• In 2020, Cook Medical acquired the lithotripsy product line from Zeiss Group. This strategic acquisition was intended to enhance Cook Medical's range of products in the urolithiasis management device market.

• Also in 2020, Olympus Corporation announced its acquisition of Lithotripsy Systems from Cybersonics, Inc. This acquisition was aimed at strengthening Olympus Corporation's market position and expanding its product offering in the urolithiasis management device market.

• Dornier MedTech GmbH unveiled the Dornier Delta III, a new lithotripter device, in 2019. This system is specifically designed to provide accurate and effective lithotripsy, thereby reducing the need for additional surgical procedures and minimizing patient discomfort.

Request a customization of the report @

Browse for more reports:

Vitamin B12 Market -

Spine Therapy Market -

Laparoscopic Scissors Market -

Insomnia Therapy Market -

Serotonin Antagonists Market -

John W.
Reports and Data
+1 212-710-1370
email us here
Visit us on social media: